Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance
Dhivya Sridaran(Washington University in St. Louis), Nupam P. Mahajan(Washington University in St. Louis)
Cited by 57
Related Papers
Ack1 Tyrosine Kinase Activation Correlates with Pancreatic Cancer Progression
|American Journal Of Pathology|2012|73
Histone H2A Lys130 acetylation epigenetically regulates androgen production in prostate cancer
|Nature Communications|2023|40
Epigenetic reprogramming of cell cycle genes by ACK1 promotes breast cancer resistance to CDK4/6 inhibitor
|Oncogene|2023|24
SHP2 as a primordial epigenetic enzyme expunges histone H3 pTyr-54 to amend androgen receptor homeostasis
|Nature Communications|2024|8